Home
Scholarly Works
Gemcitabine, dexamethasone, cisplatin (GDP)...
Conference

Gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy for relapsed or refractory Hodgkin's disease (HD): A National Cancer Institute of Canada Clinical Trials Group Study.

Authors

Crump M; Baetz T; Belch A; Couban S; Meyer R; Imrie K; Yau J; Myers R; Paul N; Turner R

Volume

100

Pagination

pp. 570A-570A

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 16, 2002

Name of conference

44th Annual Meeting of the American-Society-of-Hematology

Conference place

PHILADELPHIA, PENNSYLVANIA

Conference start date

December 6, 2002

Conference end date

December 10, 2002

Conference proceedings

BLOOD

Issue

11

ISSN

0006-4971

Contact the Experts team